Holly Yellson

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: Germany

Consulting Services

Pharma-CRO-Device Scientific Writing Journal Manuscript

Areas Of Interest

Nervous Mice Abuse, Cannabis Searching Behavior Medical Laboratory Scientists Osteosarcoma, Juxtacortical Surveys, Diet Cytoplasmic Aspartate Aminotransferase Neoplasm, Facial VGLUT Transport Proteins Gizzard, Non avian Nuclei, Rostral Intralaminar Epidermolysis Bullosa Junctionalis, Severe Nonlethal Soto Syndrome Cross Reactions Receptor CB2, Cannabinoid COS-1 Cell Oxymorphone Carinatums, Pectus Motor Neurons, Gamma Cupping Treatments Gamma Radiations Disorder, Combat Stress SED Tarda

Professional Narrative

Dr. Holly Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Amgen 2000
Senior Director, Amgen 1987

Education

Bachelor of science in nursing, Perelman School of Medicine 2016
Director Medicine, Yale School of Medicine 2006

Referees


Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :